Treating skin diseases from molecule to patient

LEO Pharma is focusing on improving outcomes for those living with skin diseases and is seeking new strategic partnerships to change the treatment paradigm in dermatology. To download the full article, please sign in.

Page of
Go to the profile of LEO Pharma A/S

LEO Pharma A/S

LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs. LEO Pharma has its own sales forces in 61 countries and employs around 4,800 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation.

Comments are disabled